Zhejiang Huahai Pharmaceutical Co Ltd Financial Flexibility Index
Zhejiang Huahai Pharmaceutical Co Ltd financial flexibility index. Zhejiang Huahai Pharmaceutical Co Ltd (600521) has a Financial Flexibility Index of 0.06x as of September 2025. Free cash flow of CN¥697.36 Million (operating CF CN¥282.81 Million minus capex CN¥414.56 Million) represents 0% of total liabilities (CN¥11.55 Billion). Explore Zhejiang Huahai Pharmaceutical Co Ltd (600521) reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Zhejiang Huahai Pharmaceutical Co Ltd (2001–2025)
Financial flexibility index of Zhejiang Huahai Pharmaceutical Co Ltd from 2001 to 2025. Historical Financial Flexibility Index trend for Zhejiang Huahai Pharmaceutical Co Ltd across 25 annual periods. Check Zhejiang Huahai Pharmaceutical Co Ltd cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Zhejiang Huahai Pharmaceutical Co Ltd Financial Flexibility Index by Year (2001–2025)
Zhejiang Huahai Pharmaceutical Co Ltd financial flexibility index by year from 2001 to 2025. Year-by-year free cash flow to debt coverage for Zhejiang Huahai Pharmaceutical Co Ltd. For the full cash flow conversion analysis, see Zhejiang Huahai Pharmaceutical Co Ltd operating cash flow efficiency.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.27x | CN¥3.20 Billion | CN¥1.23 Billion | CN¥12.05 Billion | ▼ -25.9% |
| 2024 | 0.36x | CN¥4.03 Billion | CN¥2.17 Billion | CN¥11.24 Billion | ▼ -2.7% |
| 2023 | 0.37x | CN¥3.81 Billion | CN¥2.22 Billion | CN¥10.35 Billion | ▲ +7.6% |
| 2022 | 0.34x | CN¥3.56 Billion | CN¥1.24 Billion | CN¥10.41 Billion | ▼ -11.9% |
| 2021 | 0.39x | CN¥3.37 Billion | CN¥938.43 Million | CN¥8.69 Billion | ▼ -14.1% |
| 2020 | 0.45x | CN¥2.83 Billion | CN¥1.56 Billion | CN¥6.27 Billion | ▼ -12.2% |
| 2019 | 0.51x | CN¥2.55 Billion | CN¥1.75 Billion | CN¥4.95 Billion | ▲ +165.9% |
| 2018 | 0.19x | CN¥1.19 Billion | CN¥67.90 Million | CN¥6.16 Billion | ▼ -53.6% |
| 2017 | 0.42x | CN¥1.34 Billion | CN¥546.24 Million | CN¥3.21 Billion | ▼ -23.1% |
| 2016 | 0.54x | CN¥1.17 Billion | CN¥433.10 Million | CN¥2.15 Billion | ▲ +35.4% |
| 2015 | 0.40x | CN¥719.59 Million | CN¥195.31 Million | CN¥1.80 Billion | ▼ -34.9% |
| 2014 | 0.62x | CN¥765.67 Million | CN¥328.61 Million | CN¥1.24 Billion | ▼ -6.9% |
| 2013 | 0.66x | CN¥956.53 Million | CN¥490.29 Million | CN¥1.45 Billion | ▲ +21.2% |
| 2012 | 0.55x | CN¥691.64 Million | CN¥243.83 Million | CN¥1.27 Billion | ▲ +5.1% |
| 2011 | 0.52x | CN¥543.58 Million | CN¥197.51 Million | CN¥1.05 Billion | ▼ -33.2% |
| 2010 | 0.78x | CN¥571.91 Million | CN¥299.47 Million | CN¥735.92 Million | ▼ -9.3% |
| 2009 | 0.86x | CN¥448.25 Million | CN¥317.44 Million | CN¥522.98 Million | ▲ +59.2% |
| 2008 | 0.54x | CN¥223.10 Million | CN¥84.20 Million | CN¥414.51 Million | ▼ -39.7% |
| 2007 | 0.89x | CN¥257.07 Million | CN¥136.52 Million | CN¥287.78 Million | ▼ -7.8% |
| 2006 | 0.97x | CN¥215.81 Million | CN¥77.54 Million | CN¥222.66 Million | ▼ -44.7% |
| 2005 | 1.75x | CN¥302.44 Million | CN¥53.30 Million | CN¥172.70 Million | ▼ -32.0% |
| 2004 | 2.57x | CN¥283.20 Million | CN¥163.73 Million | CN¥110.03 Million | ▲ +143.0% |
| 2003 | 1.06x | CN¥94.54 Million | CN¥47.41 Million | CN¥89.27 Million | ▲ +43.2% |
| 2002 | 0.74x | CN¥123.93 Million | CN¥75.34 Million | CN¥167.62 Million | ▲ +52.3% |
| 2001 | 0.49x | CN¥73.65 Million | CN¥37.51 Million | CN¥151.72 Million | — |